DOCS CLOSING IN ON VACCINE FOR DIABETES ; Type 1 Jab to Be Tested on People
Posted on: Tuesday, 14 December 2004, 06:00 CST
A CURE for Type 1 diabetes moved a step closer yesterday when scientists announced the first human trials of a vaccine.
One expert said the news was exciting - but warned it could be a decade before any significant progress is seen.
More than 70 patients have already been recruited to take part in the trial which will start in August next year.
Lead researcher Professor Mark Peakman, of Kings College, London, said: 'It is very exciting that we are now taking this work forward into patients.
'The early trials will tell us whether the vaccine is safe.
'We will then proceed to look at its effect on patients who have just developed diabetes and see whether the disease process can be halted.
'Following this, it would be logical to test the vaccine in individuals at risk of diabetes, to see whether prevention is possible.'
But he added: 'These trials take some years to complete, so it may be five to 10 years before we see real progress.'
Currently, people with Type 1 diabetes, the most serious form of the condition, need daily injections of synthetic insulin because the pancreas stops producing its own version of the chemical.
Type 1 diabetes affects about 300,000 people in Britain.
The new vaccine, which has already taken 10 years to develop, involves injecting a protein which stops the body destroying the cells that produce insulin, with trials proving successful in mice.
The more common Type 2 diabetes, which tends to affect the old and overweight, is increasingly being seen in kids due to the rise in childhood obesity.
Diabetes UK are supporting the trials which are being jointly run by Kings College and Bristol University.
Georgina Slack, head of research at Diabetes UK, said: 'A hundred years ago, Type 1 diabetes was a death sentence.
'Now we're seeing new approaches in research which are improving the chances of providing a cure.
'The prospect of finding a way of stopping the body from attacking itself and causing Type 1 diabetes is the holy grail of diabetes research.'
Source: Daily Record; Glasgow (UK)
Related Articles
- Many clinical trials lack patients
- Living Cell Technologies Confirms Insulin Delivery From Implants in Diabetes Clinical Trial
- Living Cell Technologies and US-Based Barbara Davis Center to Collaborate on Diabetes Clinical Trial Program
- MetaCure Initiates Diabetes Clinical Trial
- Sirtris Pharmaceuticals Initiates Phase 2a Clinical Trial in Patients With Type 2 Diabetes
- Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients With Cardiovascular Disease
- IDM Closes Enrollment to Its EP-2101 Therapeutic Vaccine Trial in Patients With Non-Small Cell Lung Cancer
- Trial Vaccine Effective Against Dog Malady
- New Analysis in Patients With Type 2 Diabetes From Trial With VYTORIN-TM- -Ezetimibe/Simvastatin- Presented at ADA; Consistent With Overall Study Which Showed Superior LDL Cholesterol Reduction With VYTORIN Versus Lipitor
- Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes: The Diabetes Prevention Trial-Type 1
 |
 |
User Comments (0)
RSS Feeds